{"entity":{"type":"insider","cik":"0001527197","url":"/insider/0001527197","json_url":"/insider/0001527197.json","name":"Bahrt Kenneth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":11,"first":"2011-09-16","last":"2018-06-27","span_basis":"filed_date"},"name_variants":[{"name":"Bahrt Kenneth","source":"filing","n_filings":11,"first_seen":"2011-09-16","last_seen":"2018-06-27"}],"transactions":[{"id":6473905,"accession":"0001209191-18-039725","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-039725","line_url":"/filing/0001209191-18-039725#line-1","is_derivative":false,"issuer_cik":"0001527197","issuer_name":"Oncobiologics, Inc.","issuer_ticker":"ONS","issuer_name_source":null,"issuer_url":"/issuer/0001527197","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7700.0,"shares_display":"7,700","price_per_share":0.8451,"price_display":"0.85","price_state":"stated","total_value":6507.27,"total_display":"6,507.27","total_whole":"6,507","shares_owned_after":47120.0,"shares_owned_after_display":"47,120","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-27","scope":"insider"},{"id":4572830,"accession":"0001209191-17-067233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-067233","line_url":"/filing/0001209191-17-067233#line-1","is_derivative":false,"issuer_cik":"0001527197","issuer_name":"Oncobiologics, Inc.","issuer_ticker":"ONS","issuer_name_source":null,"issuer_url":"/issuer/0001527197","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26165.0,"shares_display":"26,165","price_per_share":1.13,"price_display":"1.13","price_state":"stated","total_value":29566.45,"total_display":"29,566.45","total_whole":"29,566","shares_owned_after":54820.0,"shares_owned_after_display":"54,820","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-26","scope":"insider"},{"id":2549624,"accession":"0001209191-16-121073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-121073","line_url":"/filing/0001209191-16-121073#line-1","is_derivative":false,"issuer_cik":"0001527197","issuer_name":"Oncobiologics, Inc.","issuer_ticker":"ONS","issuer_name_source":null,"issuer_url":"/issuer/0001527197","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-13","filed_date":"2016-05-17","scope":"insider"},{"id":4241046,"accession":"0001181431-13-054155","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001181431-13-054155","line_url":"/filing/0001181431-13-054155","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8000.0,"shares_display":"8,000","price_per_share":0.07365625,"price_display":"0.07","price_state":"stated","total_value":589.25,"total_display":"589.25","total_whole":"589","shares_owned_after":102900.0,"shares_owned_after_display":"102,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-16","filed_date":"2013-10-17","scope":"insider","n_lines":4},{"id":4241032,"accession":"0001181431-13-054155","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-13-054155","line_url":"/filing/0001181431-13-054155","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70211.0,"shares_display":"70,211","price_per_share":0.08135664497016137,"price_display":"0.08","price_state":"stated","total_value":5712.1314,"total_display":"5,712.13","total_whole":"5,712","shares_owned_after":112572.0,"shares_owned_after_display":"112,572","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-15","filed_date":"2013-10-17","scope":"insider","n_lines":3},{"id":4394490,"accession":"0001181431-13-024355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-024355","line_url":"/filing/0001181431-13-024355#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":0.74,"price_display":"0.74","price_state":"stated","total_value":925.0,"total_display":"925.00","total_whole":"925","shares_owned_after":178211.0,"shares_owned_after_display":"178,211","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-30","filed_date":"2013-05-01","scope":"insider"},{"id":5357477,"accession":"0001181431-13-007059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-007059","line_url":"/filing/0001181431-13-007059","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":29000.0,"shares_display":"29,000","price_per_share":1.032448275862069,"price_display":"1.03","price_state":"stated","total_value":29941.0,"total_display":"29,941.00","total_whole":"29,941","shares_owned_after":171750.0,"shares_owned_after_display":"171,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-04","filed_date":"2013-02-06","scope":"insider","n_lines":2},{"id":4589420,"accession":"0001181431-13-006301","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-006301","line_url":"/filing/0001181431-13-006301#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":1.03,"price_display":"1.03","price_state":"stated","total_value":1339.0,"total_display":"1,339.00","total_whole":"1,339","shares_owned_after":200750.0,"shares_owned_after_display":"200,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-31","filed_date":"2013-02-04","scope":"insider"},{"id":2362293,"accession":"0001181431-12-057114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-057114","line_url":"/filing/0001181431-12-057114#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":1.45,"price_display":"1.45","price_state":"stated","total_value":1450.0,"total_display":"1,450.00","total_whole":"1,450","shares_owned_after":202050.0,"shares_owned_after_display":"202,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-10-31","filed_date":"2012-11-06","scope":"insider"},{"id":2555338,"accession":"0001181431-12-043396","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-043396","line_url":"/filing/0001181431-12-043396#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4950.0,"shares_display":"4,950","price_per_share":0.62,"price_display":"0.62","price_state":"stated","total_value":3069.0,"total_display":"3,069.00","total_whole":"3,069","shares_owned_after":203050.0,"shares_owned_after_display":"203,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-08-01","filed_date":"2012-08-03","scope":"insider"},{"id":8994317,"accession":"0001181431-11-056939","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-056939","line_url":"/filing/0001181431-11-056939#line-1","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.589,"price_display":"2.59","price_state":"stated","total_value":12945.0,"total_display":"12,945.00","total_whole":"12,945","shares_owned_after":58000.0,"shares_owned_after_display":"58,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-16","filed_date":"2011-11-18","scope":"insider"},{"id":9162018,"accession":"0001181431-11-049677","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-049677","line_url":"/filing/0001181431-11-049677","is_derivative":false,"issuer_cik":"0000722104","issuer_name":"SAVIENT PHARMACEUTICALS INC","issuer_ticker":"SVNT","issuer_name_source":null,"issuer_url":"/issuer/0000722104","owner_cik":"0001527197","owner_name":"Bahrt Kenneth","owner_display_name":"Bahrt Kenneth","owner_url":"/insider/0001527197","role":"Officer (SVP, Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Medical Officer","security_title":"Common Stock, $.01 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":3.9513333333333334,"price_display":"3.95","price_state":"stated","total_value":11854.0,"total_display":"11,854.00","total_whole":"11,854","shares_owned_after":52500.0,"shares_owned_after_display":"52,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-14","filed_date":"2011-09-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649989","name":"Oncobiologics, Inc.","url":"/issuer/0001649989","role":"Officer (Chief Medical Officer)","n_filings":3,"first_seen":"2016-05-17","last_seen":"2018-06-27"},{"type":"issuer","type_label":"ISSUER","cik":"0000722104","name":"SAVIENT PHARMACEUTICALS INC","url":"/issuer/0000722104","role":"Officer (SVP, Chief Medical Officer)","n_filings":8,"first_seen":"2011-09-16","last_seen":"2013-10-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001527197","retrieved_at":"2026-08-24T11:08:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}